Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The CD81 partner EWI-2wint inhibits hepatitis C virus entry.

Rocha-Perugini V, Montpellier C, Delgrange D, Wychowski C, Helle F, Pillez A, Drobecq H, Le Naour F, Charrin S, Levy S, Rubinstein E, Dubuisson J, Cocquerel L.

PLoS One. 2008 Apr 2;3(4):e1866. doi: 10.1371/journal.pone.0001866.

2.

EWI-2wint--a host cell factor inhibiting hepatitis C virus entry.

Schuster C, Baumert TF.

J Hepatol. 2009 Jan;50(1):222-4. doi: 10.1016/j.jhep.2008.10.009. Epub 2008 Nov 5.

PMID:
19019480
3.

Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection.

Montpellier C, Tews BA, Poitrimole J, Rocha-Perugini V, D'Arienzo V, Potel J, Zhang XA, Rubinstein E, Dubuisson J, Cocquerel L.

J Biol Chem. 2011 Apr 22;286(16):13954-65. doi: 10.1074/jbc.M111.220103. Epub 2011 Feb 22.

4.

EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.

Potel J, Rassam P, Montpellier C, Kaestner L, Werkmeister E, Tews BA, Couturier C, Popescu CI, Baumert TF, Rubinstein E, Dubuisson J, Milhiet PE, Cocquerel L.

Cell Microbiol. 2013 Jul;15(7):1234-52. doi: 10.1111/cmi.12112. Epub 2013 Feb 16.

PMID:
23351194
5.

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.

Rocha-Perugini V, Lavie M, Delgrange D, Canton J, Pillez A, Potel J, Lecoeur C, Rubinstein E, Dubuisson J, Wychowski C, Cocquerel L.

BMC Microbiol. 2009 May 28;9:111. doi: 10.1186/1471-2180-9-111.

6.

Hepatitis C virus entry into host cells.

Helle F, Dubuisson J.

Cell Mol Life Sci. 2008 Jan;65(1):100-12. Review.

PMID:
17914604
7.

Binding of hepatitis C virus to CD81.

Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S.

Science. 1998 Oct 30;282(5390):938-41.

8.

CD81 is an entry coreceptor for hepatitis C virus.

Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T.

Proc Natl Acad Sci U S A. 2004 May 11;101(19):7270-4. Epub 2004 May 3.

9.

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P.

J Virol. 2004 Aug;78(16):8496-505.

10.

Structure-function analysis of hepatitis C virus envelope-CD81 binding.

Petracca R, Falugi F, Galli G, Norais N, Rosa D, Campagnoli S, Burgio V, Di Stasio E, Giardina B, Houghton M, Abrignani S, Grandi G.

J Virol. 2000 May;74(10):4824-30.

11.
12.

EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.

Charrin S, Le Naour F, Labas V, Billard M, Le Caer JP, Emile JF, Petit MA, Boucheix C, Rubinstein E.

Biochem J. 2003 Jul 15;373(Pt 2):409-21.

13.

Diverse CD81 proteins support hepatitis C virus infection.

Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA.

J Virol. 2006 Nov;80(22):11331-42. Epub 2006 Aug 30.

14.

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA.

J Virol. 2004 Feb;78(3):1448-55.

15.

Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain.

Yalaoui S, Zougbédé S, Charrin S, Silvie O, Arduise C, Farhati K, Boucheix C, Mazier D, Rubinstein E, Froissard P.

PLoS Pathog. 2008 Feb 29;4(2):e1000010. doi: 10.1371/journal.ppat.1000010.

16.

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.

Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, Scarselli E, Cortese R, Nicosia A, Cosset FL.

J Biol Chem. 2003 Oct 24;278(43):41624-30. Epub 2003 Aug 11.

17.

Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, Levy S, von Weizsäcker F, Blum HE, Baumert TF.

J Clin Invest. 2002 Jan;109(2):221-32.

18.

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM.

Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.

19.

Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

Owsianka A, Clayton RF, Loomis-Price LD, McKeating JA, Patel AH.

J Gen Virol. 2001 Aug;82(Pt 8):1877-83.

PMID:
11457993
20.

CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.

Zhang S, Kodys K, Babcock GJ, Szabo G.

Hepatology. 2013 Sep;58(3):940-9. doi: 10.1002/hep.25827. Epub 2013 Jan 18.

Supplemental Content

Support Center